Operator: Welcome to the conference call hosted by Daré Bioscience to review the Company’s Financial Results for the Quarter Ended March 31, 2023, and to provide a General Business Update.
Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) was the target of a large decline in short interest during the month of April. As of April 30th, there was short interest totalling 511,000 shares, a decline of 16.6% from the April 15th total of 612,400 shares. Based on an average trading volume of 203,300 shares, the […]
Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) was the recipient of a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 612,400 shares, an increase of 12.5% from the March 31st total of 544,400 shares. Based on an average daily trading volume, of 283,800 shares, […]
Shares of Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $1.08 and traded as low as $0.97. Daré Bioscience shares last traded at $0.98, with a volume of 74,549 shares traded. Analyst Ratings Changes A […]